Control and regulation of peripheral tolerance in allergic inflammatory disease: Therapeutic consequences

Chemical Immunology and Allergy

Volumn 94, Issue , 2008, Pages 178-188

  Li, L ^a   Boussiotis, V ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALTRAKINCEPT; DIACYLGLYCEROL; DNA VACCINE; GAMMA INTERFERON; GRASS POLLEN EXTRACT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MONOCLONAL ANTIBODY INTERLEUKIN 5; OMALIZUMAB; PEPTIDE DERIVATIVE; PHOSPHOLIPASE; PROSTAGLANDIN G2; PROSTAGLANDIN H2; PROTEIN KINASE SYK; RECOMBINANT DNA; THYMIC STROMAL LYMPHOPOIETIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ANTIGEN SPECIFICITY; CD25+ T LYMPHOCYTE; CLONAL ANERGY; CYTOKINE PRODUCTION; DESENSITIZATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INFLAMMATION; INNATE IMMUNITY; MAST CELL; NATURAL KILLER T CELL; NONHUMAN; POLLEN ALLERGY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH2 CELL;

ALLERGENS; ANIMALS; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; OLIGONUCLEOTIDES; PEPTIDES; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VACCINES, DNA;

EID: 52249089169     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000155086     Document Type: Review

References (37)

1. Umetsu DT, Dekruyff RH: Immune dysregulation in asthma. Curr Opin Immunol 2006;18:727-732.
2. Kay AB: Allergy and allergic diseases. First of two parts. N Engl J Med 2001;344:30-37.
3. Jutel M, Akdis M, Blaser K, Akdis CA: Mechanisms of allergen-specific immunotherapy - T-cell tolerance and more. Allergy 2006;61:796-807.
4. Macaubas C, Wahlstrom J, Galvao da Silva AP, Forsthuber TG, Sonderstrup G, Kwok WW, DeKruyff RH, Umetsu DT: Allergen-specific MHC class II tetramer+ cells are detectable in allergic, but not in nonallergic, individuals. J Immunol 2006;176:5069-5077.
5. Umetsu SE, Lee WL, McIntire JJ, Downey L, Sanjanwala B, Akbari O, Berry GJ, Nagumo H, Freeman GJ, Umetsu DT, DeKruyff RH: TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol 2005;6:447-454.
6. McIntire JJ, Umetsu SE, Macaubas C, Hoyte EG, Cinnioglu C, Cavalli-Sforza LL, Barsh GS, Hallmayer JF, Underhill PA, Risch NJ, Freeman GJ, DeKruyff RH, Umetsu DT: Immunology: hepatitis A virus link to atopic disease. Nature 2003;425:576.
7. Bach JF: The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-920.
8. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, Thunberg S, Deniz G, Valenta R, Fiebig H, Kegel C, Disch R, Schmidt-Weber CB, Blaser K, Akdis CA: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T-helper 2 cells. J Exp Med 2004;199:1567-1575.
9. 1 gene results in multifocal inflammatory disease. Nature 1992;359:693-699.
10. Sonoda E, Matsumoto R, Hitoshi Y, Ishii T, Sugimoto M, Araki S, Tominaga A, Yamaguchi N, Takatsu K: Transforming growth factor-β induces IgA production and acts additively with interleukin-5 for IgA production. J Exp Med 1989;170:1415-1420.
11. Ostroukhova M, Qi Z, Oriss TB, Dixon-McCarthy B, Ray P, Ray A: Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-β. J Clin Invest 2006;116:996-1004.
12. Wilson MS, Taylor MD, Balic A, Finney CA, Lamb JR, Maizels RM: Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 2005;202:1199-1212.
13. Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH, Bradding P, Brightling CE, Wardlaw AJ, Pavord ID: Evidence of a role of tumor necrosis factor-α in refractory asthma. N Engl J Med 2006;354:697-708.
14. Liu YJ: Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006;203:269-273.
15. Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, Sampietro GM, Nespoli A, Viale G, Allavena P, Rescigno M: Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005;6:507-514.
16. Hurst SD, Muchamuel T, Gorman DM, Gilbert JM, Clifford T, Kwan S, Menon S, Seymour B, Jackson C, Kung TT, Brieland JK, Zurawski SM, Chapman RW, Zurawski G, Coffman RL: New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002;169:443-453.
17. Meyer EH, Goya S, Akbari O, Berry GJ, Savage PB, Kronenberg M, Nakayama T, DeKruyff RH, Umetsu DT: Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc Natl Acad Sci USA 2006;103:2782-2787.
18. Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M, DeKruyff RH, Umetsu DT: CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med 2006;354:1117-1129.
19. Akira S, Takeda K, Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-680.
20. Durham SR, Till SJ: Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998;102:157-164.
21. 2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998;101:747-754.
22. Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O: Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005;116:608-613.
23. Oldfield WL, Larche M, Kay AB: Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 2002;360:47-53.
24. Larche M, Wraith DC: Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 2005;11:S69-S76.
25. Karamloo F, Schmid-Grendelmeier P, Kussebi F, Akdis M, Salagianni M, von Beust BR, Reimers A, Zumkehr J, Soldatova L, Housley-Markovic Z, Muller U, Kundig T, Kemeny DM, Spangfort MD, Blaser K, Akdis CA: Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopes. Eur J Immunol 2005;35:3268-3276.
26. Kussebi F, Karamloo F, Rhyner C, Schmid-Grendelmeier P, Salagianni M, Mannhart C, Akdis M, Soldatova L, Markovic-Housley Z, Von Beust BR, Kundig T, Kemeny DM, Blaser K, Crameri R, Akdis CA: A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy. J Allergy Clin Immunol 2005;115:323-329.
27. Gafvelin G, Thunberg S, Kronqvist M, Gronlund H, Gronneberg R, Troye-Blomberg M, Akdis M, Fiebig H, Purohit A, Horak F, Reisinger J, Niederberger V, Akdis CA, Cromwell O, Pauli G, Valenta R, van Hage M: Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1. Int Arch Allergy Immunol 2005;138:59-66.
28. Tighe H, Corr M, Roman M, Raz E: Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today 1998;19:89-97.
29. Hessel EM, Chu M, Lizcano JO, Chang B, Herman N, Kell SA, Wills-Karp M, Coffman RL: Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction. J Exp Med 2005;202:1563-1573.
30. Bashir ME, Louie S, Shi HN, Nagler-Anderson C: Toll-like receptor-4 signaling by intestinal microbes influences susceptibility to food allergy. J Immunol 2004;172:6978-6987.
31. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-241.
32. MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie-White J, Sterbinsky SA, Hamilton RG, Lichtenstein LM: Downregulation of Fc-RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438-1445.
33. Borish LC, Nelson HS, Lanz MJ, Claussen L, Whitmore JB, Agosti JM, Garrison L: Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999;160:1816-1823.
34. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148.
35. Verhoef A, Alexander C, Kay AB, Larche M: T cell epitope immunotherapy induces a CD4+ T-cell population with regulatory activity. PLoS Med 2005;2:e78.
36. Frick OL, Teuber SS, Buchanan BB, Morigasaki S, Umetsu DT: Allergen immunotherapy with heat-killed Listeria monocytogenes alleviates peanut and food-induced anaphylaxis in dogs. Allergy 2005;60:243-250.
37. Stock P, Akbari O, DeKruyff RH, Umetsu DT: Respiratory tolerance is inhibited by the administration of corticosteroids. J Immunol 2005;175:7380-7387.